Respiratory distress due to minocycline-induced pulmonary lupus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10334177.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Minoeycline, a semisynthetic tetracycline, is often used to treat acne and rheumatoid arthritis. It has been considered an unlikely drug to be associated with systemic lupus erythematosus; however, many cases of drug-induced lupus related to minocycline have been reported. Some of those reports included pulmonary lupus, but none of the patients described developed respiratory distress. We describe a patient treated with minocycline for 2 years who presented with progressive dyspnea, severe hypoxia, and pulmonary infiltrates necessitating hospitalization and oxygen supplementation.
Medical subject headings
- Anti-Bacterial Agents
- Lung Diseases
- Lupus Erythematosus, Systemic
- Minocycline
- Respiratory Insufficiency